Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2014

May 19, 2014

30826_dirs_2014-05-19_3ca6418e-e8f5-42ba-a69c-cc01ef34f8c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-05-15

Reporting Person: GRIFFITH MICHAEL A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-15 Common Stock A 1932 Acquired 9274 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-15 Stock Option (Right to Buy) $18.12 A 3696 Acquired 2024-05-15 Common Stock (3696) Direct

Footnotes

F1: Mr. Griffith was awarded 1,932 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 15, 2015. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

F2: Award vests in full one year from grant date on May 15, 2015.